pentobarbital will decrease the level or effect of roflumilast samhälle affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration anmärkning recommended; strong cytochrome P450 enzyme inducers decrease systemic exposure to roflumilast knipa may reduce the therapeutic effectivenessActivated samhälle the antibiotic r